The short version of reverse-phase HPLC fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-22 and is reviewed periodically as new material appears.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
| Property | Value | Notes |
|---|---|---|
| Common route | Intranasal | Also injected in some animal work |
| Solubility class | Freely soluble in water | Solid form is hygroscopic |
| Typical storage | About -20 degrees Celsius | Keep desiccated and dark |
| Purity method | Reverse-phase HPLC | Reported as area percent |
| Confirmatory method | Mass spectrometry | Verifies expected molecular mass |
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
== Clinical significance == Mutations in the POMC gene have been associated with early-onset obesity, adrenal insufficiency, and red hair pigmentation. In cases of primary adrenal insufficiency, decreased cortisol production leads to compensatory overproduction of pituitary ACTH through feedback mechanisms. Because ACTH is co-produced with α-MSH and γ-MSH from POMC, this overproduction can result in hyperpigmentation. A specific genetic polymorphism in the POMC gene is associated with elevated fasting insulin levels, but only in obese individuals. The melanocortin signaling pathway may influence glucose metabolism in the context of obesity, indicating a possible gene–environment interaction. Thus, POMC variants may contribute to the development of polygenic obesity and help explain the connection between obesity and type 2 diabetes. Increased circulating levels of POMC have also been observed in patients with sepsis. While the clinical implications of this finding are still under investigation, animal studies have shown that infusion of hydrocortisone in septic mice suppresses ACTH (a downstream product of POMC) without reducing POMC levels themselves.
It was a serious public-relations problem for Abbott, so the company held interviews and press conferences, at which senior Abbott officials answered questions. The transcripts are archived at [1]. A later study found 3 additional morphs: a metastable polymorph, a trihydrate, and a formamide solvate.
=== Scintigraphy/radionuclide imaging === Scintigraphy can be used to measure the extent and distribution of the amyloid throughout the body, including the liver, kidney, spleen, and heart. A radiolabelled serum amyloid P component can be administered to a patient intravenously and the P component pools to the amyloid deposit proportional to the size of the deposit. The labeling of the P component can then be pictured by a gamma camera. Technetium radionuclide scans can now reliably diagnosis cardiac amyloidosis, with certain scanning methods having greater than 99% sensitivity (but only 91% specific for amyloidosis). In this method of imaging, radiolabeled technetium is injected into the body where it binds to cardiac amyloid deposits. A subsequent scan is taken to determine where the tracer stays, therefore highlighting the amyloid deposition in the heart. This method allows for a noninvasive definitive diagnosis of cardiac amyloidosis (as in the past an endomyocardial biopsy was required)
Sources: en.wikipedia.org
Instrument Landing System (ILS) - A short range radio navigation aid at airports which guides aircraft landing in low visibility conditions. It consists of multiple antennas at the end of each runway that radiate two beams of radio waves along the approach to the runway: the localizer (108 to 111.95 MHz frequency), which provides horizontal guidance, a heading line to keep the aircraft centered on the runway, and the glideslope (329.15 to 335 MHz) for vertical guidance, to keep the aircraft descending at the proper rate for a smooth touchdown at the correct point on the runway. Each aircraft has a receiver instrument and antenna which receives the beams, with an indicator to tell the pilot whether he is on the correct horizontal and vertical approach. The ILS beams are receivable for at least 15 miles, and have a radiated power of 25 watts. ILS systems at airports are being replaced by systems that use satellite navigation. Non-directional beacon (NDB) – Legacy fixed radio beacons used before the VOR system that transmit a simple signal in all directions for aircraft or ships to use for radio direction finding. Aircraft use automatic direction finder (ADF) receivers which use a directional antenna to determine the bearing to the beacon. By taking bearings on two beacons they can determine their position. NDBs use frequencies between 190 and 1750 kHz in the LF and MF bands which propagate beyond the horizon as ground waves or skywaves much farther than VOR beacons. They transmit a callsign consisting of one to 3 Morse code letters as an identifier.
reassociation kinetics The measurement and manipulation of the rate of reannealing of complementary strands of DNA, generally by heating and denaturing a double-stranded molecule into single strands and then observing their rehybridization at a cooler temperature. Because the base pair G+C requires more energy to anneal than the base pair A+T, the rate of reannealing between two strands depends partly on their nucleotide sequence, and it is therefore possible to predict or estimate the sequence of the duplex molecule by the time it takes to fully hybridize. Reassociation kinetics is studied with C0t analysis: fragments reannealing at low C0t values tend to have highly repetitive sequences, while higher C0t values imply more unique sequences.
Zverev started his 2022 season by representing Germany at the ATP Cup. Germany was in Group C alongside Great Britain, the US, and Canada. Against Great Britain, he beat Cameron Norrie. Great Britain ended up winning the tie over Germany 2–1. Against the US, he defeated Taylor Fritz. Germany won the tie 2–1 over the USA. Against Canada, he lost to Félix Auger-Aliassime in three sets. Canada won the tie over Germany 2–1. Germany not only failed to qualify for the semi-finals, but they also ended third in Group C. Seeded third at the Australian Open, he reached the fourth round where he was defeated by 14th seed, Denis Shapovalov, in straight sets. After the Australian Open, Zverev played at the Open Sud de France. As the top seed, he made it to the final where he lost to sixth seed Alexander Bublik. Seeded second at the Mexican Open, Zverev played in what was the record latest match ever played, defeating Jenson Brooksby at 4:55 A.M. He was then defaulted from the tournament ahead of his following match against compatriot, Peter Gojowczyk, for violently and repeatedly hitting the umpire's chair with his racket after his loss in doubles. Representing Germany in the Davis Cup tie against Brazil, he won both of his matches by beating Thiago Seyboth Wild and Thiago Monteiro. Germany ended up winning the tie over Brazil 3–1 to qualify for the Davis Cup Finals. Seeded third at the Indian Wells Masters, he was stunned in his second-round match by Tommy Paul.
Until January 1918, the Free Cossacks of Ukraine were subordinate to the Ukrainian General Secretariat of Internal Affairs. With the beginning of the Ukrainian-Soviet War, their units were incorporated into the regular army. However, after a number of battles against the Bolsheviks, Free Cossacks were disarmed in compliance with orders of the German command, whose troops had occupied Ukraine in March–April 1918 after the Treaty of Brest-Litovsk. On 29 April 1918 Pavlo Skoropadskyi, the earlier leader of Free Cossacks, was proclaimed Hetman of Ukraine at a congress of the conservative All-Ukrainian Union of Landowners. This coup was backed by generals of German and Austrian armies which were occupying Ukraine at that time. The previously democratic Ukrainian People's Republic was replaced with the Hetmanate, the Central Rada and the Council of Ministers of the Ukrainian People's Republic were abolished, with all their powers, as well as command over the military, being transferred to Skoropadskyi, and private land ownership was reinstated. Local administration was entrusted to commissioners personally appointed by the hetman. To achieve legitimacy among the Ukrainian population, the Skoropadskyi styled his regime as a continuation of Ukrainian Cossack traditions of the 17-18th centuries. The hetman's government included representatives of old Cossack nobility (starshyna), most prominently Fedir Lyzohub (head of the Conucil of Ministers) and Dmytro Doroshenko (Minister of Foreign Affairs).
Sources: en.wikipedia.org
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.
Reported human trials are few, brief and originate mainly from one country. They describe effects on anxiety-related measures, but sample sizes are small and reporting is limited. The results are widely regarded as preliminary rather than confirmed.
Reverse-phase liquid chromatography is used to assess purity and separation of related impurities. Mass spectrometry confirms that the observed molecular mass matches the expected peptide. A certificate of analysis from the supplier is the usual document of record.
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.